The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Wigginton Jon Marc since 2014.
The trader's CIK number is 1587487.
At the time of the last reporting, Wigginton Jon Marc was the Senior VP, Clinical Dev. of Macrogenics Inc. (stock ticker symbol MGNX).
Also see all insider trading activities at Macrogenics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | MGNX | 0 | $0 | 5,000 | $100,000 | 5,000 | $23,499 |
| 2017 | MGNX | 0 | $0 | 35,000 | $700,000 | 35,000 | $164,500 |
| 2016 | MGNX | 0 | $0 | 45,000 | $1,341,500 | 45,000 | $211,500 |
| 2015 | MGNX | 0 | $0 | 30,000 | $972,300 | 30,000 | $141,000 |
| 2014 | MGNX | 0 | $0 | 10,000 | $205,000 | 10,000 | $47,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-01-16 | MGNX | Sale | 2,476 | 20.00 | 49,520 |
| 2018-01-17 | MGNX | Sale | 2,524 | 20.00 | 50,480 |
| 2018-01-16 | MGNX | Option Ex | 2,476 | 4.70 | 11,637 |
| 2018-01-17 | MGNX | Option Ex | 2,524 | 4.70 | 11,862 |
| 2017-11-21 | MGNX | Option Ex | 5,000 | 4.70 | 23,500 |
| 2017-11-21 | MGNX | Sale | 5,000 | 20.00 | 100,000 |
| 2017-10-25 | MGNX | Option Ex | 10,000 | 4.70 | 47,000 |
| 2017-10-25 | MGNX | Sale | 10,000 | 20.00 | 200,000 |
| 2017-06-05 | MGNX | Sale | 5,000 | 20.00 | 100,000 |
| 2017-06-05 | MGNX | Option Ex | 5,000 | 4.70 | 23,500 |
| 2017-04-19 | MGNX | Option Ex | 15,000 | 4.70 | 70,500 |
| 2017-04-19 | MGNX | Sale | 15,000 | 20.00 | 300,000 |
| 2016-10-03 | MGNX | Option Ex | 10,000 | 4.70 | 47,000 |
| 2016-10-03 | MGNX | Sale | 10,000 | 29.34 | 293,400 |
| 2016-08-01 | MGNX | Option Ex | 20,000 | 4.70 | 94,000 |
| 2016-08-01 | MGNX | Sale | 20,000 | 30.78 | 615,600 |
| 2016-07-01 | MGNX | Option Ex | 5,000 | 4.70 | 23,500 |
| 2016-07-01 | MGNX | Sale | 5,000 | 27.22 | 136,100 |
| 2016-01-04 | MGNX | Option Ex | 10,000 | 4.70 | 47,000 |
| 2016-01-04 | MGNX | Sale | 10,000 | 29.64 | 296,400 |
| 2015-10-01 | MGNX | Option Ex | 5,000 | 4.70 | 23,500 |
| 2015-10-01 | MGNX | Sale | 5,000 | 21.11 | 105,550 |
| 2015-08-03 | MGNX | Option Ex | 10,000 | 4.70 | 47,000 |
| 2015-08-03 | MGNX | Sale | 10,000 | 37.15 | 371,500 |
| 2015-07-01 | MGNX | Sale | 5,000 | 37.15 | 185,750 |
| 2015-07-01 | MGNX | Option Ex | 5,000 | 4.70 | 23,500 |
| 2014-04-01 | MGNX | Option Ex | 5,000 | 4.70 | 23,500 |
| 2015-04-01 | MGNX | Sale | 5,000 | 30.86 | 154,300 |
| 2015-02-02 | MGNX | Sale | 5,000 | 31.04 | 155,200 |
| 2015-02-02 | MGNX | Option Ex | 5,000 | 4.70 | 23,500 |
| 2014-10-01 | MGNX | Sale | 5,000 | 20.48 | 102,400 |
| 2014-10-01 | MGNX | Option Ex | 5,000 | 4.70 | 23,500 |
| 2014-08-18 | MGNX | Option Ex | 5,000 | 4.70 | 23,500 |
| 2014-08-18 | MGNX | Sale | 5,000 | 20.52 | 102,600 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wigginton Jon Marc (Senior VP, Clinical Dev. of Macrogenics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.